The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis
Abstract
OBJECTIVE: The objective of this study was to evaluate montelukast 10 mg daily as treatment for allergic rhinitis in patients with symptomatic allergic rhinitis and active asthma during the allergy season. METHODS: This was a multicenter study of 831 patients (ages 15 years-85 years) with seasonal allergen sensitivity, active symptoms of seasonal allergic rhinitis, and active asthma. Following a single-blind, placebo run-in period of 3 days-5 days, patients were randomized to oral montelukast 10 mg (n = 415) or placebo (n = 416) daily during the 2-week, double-blind, active-treatment period. MAIN OUTCOME MEASURES: The primary endpoint was Daily Rhinitis Symptoms score, average of Daytime Nasal Symptoms and Nighttime Symptoms, as self-rated by patients on a 0-3 scale on daily diaries. RESULTS: Montelukast reduced the Daily Rhinitis Symptoms score: difference between montelukast and placebo in mean change from baseline was -0.12 [95% CI -0.18, -0.06; p < or = 0.001]. Similar improvements were seen in Daytime Nasal Symptoms (-0.14 [-0.21, -0.07; p < or = 0.001]) and Nighttime Symptoms (-0.10 [-0.16, -0.04; p < or = 0.001]). Improvements (p < 0.05) were seen in Daytime Eye Symptoms and in the secondary endpoints of Global Evaluations of AR by Patient and by Physician, and Rhinoconjunctivitis Quality of Life. In exploratory analyses, improvement in rhinitis symptoms was numerically (though not statistically) larger in patients with greater levels of asthma at study start. Montelukast provided benefit in the Global Evaluations of Asthma by Patient and by Physician: mean differences were -0.24 [-0.41, -0.06; p = 0.008] and -0.17 [-0.33, -0.01; p = 0.037]. Similarly, as-needed beta-agonist use (puffs/day) was reduced with montelukast (p < or = 0.005). CONCLUSION: Montelukast provides significant relief from symptoms of seasonal allergic rhinitis, while also conferring a benefit for asthma, in patients with both allergic rhinitis and asthma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Allergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
Quality of Life in Allergic Rhinitis and Asthma
LEYNAERT, B., NEUKIRCH, C., LIARD, R., BOUSQUET, J., & NEUKIRCH, F. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.4.9912033 · Cited by 407
Segmental Bronchial Provocation Induces Nasal Inflammation in Allergic Rhinitis Patients
BRAUNSTAHL, G.-J., KLEINJAN, A., OVERBEEK, S. E., PRINS, J.-B., HOOGSTEDEN, H. C., & FOKKENS, W. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.6.9906121 · Cited by 399
Nasal involvement in allergic asthma
Braunstahl, G. ‐., & Fokkens, W. (2003) · Allergy · doi:10.1046/j.0105-4538.2003.00354.x · Cited by 102
Cited by
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
Bousquet, J., Khaltaev, N., Cruz, A. A., Denburg, J., Fokkens, W. J., Togias, A., Zuberbier, T., Baena‐Cagnani, C. E., Canonica, G. W., Van Weel, C., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01620.x · Cited by 4,729
“In studies carried out on patients with seasonal allergic rhinitis and asthma, montelukast was found to improve nasal and bronchial symptoms (1588, 1589).”
BackgroundGlobal strategy for asthma management and prevention: GINA executive summary
Bateman, E. D., Hurd, S. S., Barnes, P. J., Bousquet, J., Drazen, J. M., FitzGerald, M., Gibson, P., Ohta, K., O'Byrne, P., Pedersen, S. E., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00138707 · Cited by 3,203
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
Brożek, J. L., Bousquet, J., Baena-Cagnani, C. E., Bonini, S., Canonica, G. W., Casale, T. B., van Wijk, R. G., Ohta, K., Zuberbier, T., & Schünemann, H. J. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.06.047 · Cited by 1,813
“In studies carried out on patients with seasonal allergic rhinitis and asthma, montelukast was found to improve nasal and bronchial symptoms (1588, 1589).”
BackgroundClinical Practice Guideline: Allergic Rhinitis
Seidman, M. D., Gurgel, R. K., Lin, S. Y., Schwartz, S. R., Baroody, F. M., Bonner, J. R., Dawson, D. E., Dykewicz, M. S., Hackell, J. M., Han, J. K., et al. (2015) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599814561600 · Cited by 671
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
Rhinitis 2020: A practice parameter update
Dykewicz, M. S., Wallace, D. V., Amrol, D. J., Baroody, F. M., Bernstein, J. A., Craig, T. J., Dinakar, C., Ellis, A. K., Finegold, I., Golden, D. B. K., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.07.007 · Cited by 436
BSACI guidelines for the management of allergic and non‐allergic rhinitis
Scadding, G. K., Durham, S. R., Mirakian, R., Jones, N. S., Leech, S. C., Farooque, S., Ryan, D., Walker, S. M., Clark, A. T., Dixon, T. A., et al. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2007.02888.x · Cited by 375
Scadding, G. K., Kariyawasam, H. H., Scadding, G., Mirakian, R., Buckley, R. J., Dixon, T., Durham, S. R., Farooque, S., Jones, N., Leech, S., et al. (2017) · Clinical & Experimental Allergy · doi:10.1111/cea.12953 · Cited by 359
Chauhan, B. F., & Ducharme, F. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002314.pub3 · Cited by 306
Influence of comorbid conditions on asthma
Boulet, L.-P. (2009) · European Respiratory Journal · doi:10.1183/09031936.00121308 · Cited by 262
Cruz, A. A., Popov, T., Pawankar, R., Annesi‐Maesano, I., Fokkens, W., Kemp, J., Ohta, K., Price, D., Bousquet, J., & on behalf of ARIA Initiative Scientific Committee (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01551.x · Cited by 258
Boulet, L.-P., & Boulay, M.-È. (2011) · Expert Review of Respiratory Medicine · doi:10.1586/ers.11.34 · Cited by 254
Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report
Papadopoulos, N. G., Bernstein, J. A., Demoly, P., Dykewicz, M., Fokkens, W., Hellings, P. W., Peters, A. T., Rondon, C., Togias, A., & Cox, L. S. (2015) · Allergy · doi:10.1111/all.12573 · Cited by 182
“, the vast majority of patients with allergic asthma), montelukast may be advantageous over AHs because of its potential to offer benefits in both conditions (200).”
BackgroundBurden of Concomitant Allergic Rhinitis in Adults with Asthma
Gaugris, S., Sazonov-Kocevar, V., & Thomas, M. (2006) · Journal of Asthma · doi:10.1080/02770900500446823 · Cited by 97
“Indeed, a recent large (n = 831) randomized double-blind multinational clinical trial demonstrated that montelukast relieves symptoms of allergic rhinitis and improves asthma outcomes in patients with asthma and AR (44).”
BackgroundAllergic rhinitis: the “Ghost Diagnosis” in patients with asthma
Egan, M., & Bunyavanich, S. (2015) · Asthma Research and Practice · doi:10.1186/s40733-015-0008-0 · Cited by 64
Metadata
- Authors
- Philip, G., Nayak, A. S., Berger, W. E., Leynadier, F., Vrijens, F., Dass, S. B., & Reiss, T. F.
- Venue
- Current Medical Research and Opinion
- Publisher
- Informa Healthcare
- Published
- 2004-09-20
- Volume
- 20
- Issue
- 10
- Pages
- 1549-1558
- ISSN
- 0300-7995 (ISSN-L)
- 1473-4877
- OpenAlex
- W1998515501
- Cited by
- 183
- References
- 4
- FWCI
- 8.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.